Recommended dosing schedules1:
MODERATE-TO-SEVERE ASTHMA WITH AN EOSINOPHILIC PHENOTYPE
OCS-DEPENDENT ASTHMA PATIENTS, OR PATIENTS WITH CO-MORBID MODERATE-TO-SEVERE ATOPIC DERMATITIS, FOR WHOM DUPIXENT IS INDICATED
- Initial dose is 600 mg (two 300 mg pre-filled syringes) followed 2 weeks later by
every-other-week dosing of a 300 mg pre-filled syringe
DUPIXENT is intended for use under the guidance of a healthcare provider. A patient may self-inject DUPIXENT after training in subcutaneous injection technique using the pre-filled syringe. Provide proper training to patients and/or caregivers on the preparation and administration of DUPIXENT prior to use according to the Instructions for Use.
- DUPIXENT can be administered in the office under the guidance of a healthcare provider if the patient is not an appropriate candidate for self-administration
- a 300 mg=2 mL solution.
- b 200 mg=1.14 mL solution.